Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Research article

Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis

Authors: Zhe Wang, Aili Jiang, Fang Wei, Haiyan Chen

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Background

Vascular calcification is a risk factor for the pathogenesis of cardiovascular disease and mortality in dialysis patients. Nevertheless, the association between cardiac valve calcification (CVC) and the outcome of dialysis is still illusive. The purpose of this meta-analysis is to evaluate the association between theCVC and cardiovascular or all-cause mortality in dialysis patients.

Methods

Literatures involving the baseline CVC and cardiovascular or all-cause mortality in dialysis patients were searchedfrom the PubMed, Embase, as well as two Chinese databases (i.e. Wanfang and CNKI databases). Articles published before November 2016were eligible to the study.

Results

Ten studies involving 2686 participants were included. CVC was correlated with increased risk of cardiovascular mortality (hazard risk [HR]: 2.81; 95% confidence intervals [CI]: 1.92–4.10) and all-cause mortality (HR: 1.73; 95% CI: 1.42–2.11). Subgroup analysis showed an excess risk of all-cause mortality (HR: 1.35; 95% CI: 1.02–1.79) among patients with one CVC, and increased risk of all-cause mortality in patients with two CVCs (HR 2.15; 95% CI 1.57–2.94).

Conclusions

CVC is correlated with higher cardiovascular and all-cause mortality risk in dialysis patients. Regular follow-up monitoring of CVC may be helpful for risk stratification of patients underwent dialysis.
Literature
1.
go back to reference Bover J, Ureña-Torres P, Górriz JL, et al. Cardiovascular calcifications in chronic kidney disease: potential therapeutic implications. Nefrologia. 2016;36(6):597–608.CrossRefPubMed Bover J, Ureña-Torres P, Górriz JL, et al. Cardiovascular calcifications in chronic kidney disease: potential therapeutic implications. Nefrologia. 2016;36(6):597–608.CrossRefPubMed
2.
go back to reference Karohl C, D'MarcoGascón L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease[J]. Nat Rev Nephrol. 2011;7(10):567–77.CrossRefPubMed Karohl C, D'MarcoGascón L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease[J]. Nat Rev Nephrol. 2011;7(10):567–77.CrossRefPubMed
3.
go back to reference Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone. 2016 Nov;12 [Epub ahead of print] Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone. 2016 Nov;12 [Epub ahead of print]
4.
go back to reference Bellasi A, Ferramosca E, Ratti C, et al. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol. 2012;25(1):211–8.CrossRefPubMed Bellasi A, Ferramosca E, Ratti C, et al. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol. 2012;25(1):211–8.CrossRefPubMed
5.
go back to reference Takahashi H, Ishii H, Aoyama T, et al. Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study. Am J Kidney Dis. 2013;61(2):254–61.CrossRefPubMed Takahashi H, Ishii H, Aoyama T, et al. Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study. Am J Kidney Dis. 2013;61(2):254–61.CrossRefPubMed
6.
go back to reference Panuccio V, Tripepi R, Tripepi G, et al. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis. 2004;43(3):479–84.CrossRefPubMed Panuccio V, Tripepi R, Tripepi G, et al. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis. 2004;43(3):479–84.CrossRefPubMed
7.
go back to reference Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J ClinEpidemiol. 2009;62(10):1006–12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J ClinEpidemiol. 2009;62(10):1006–12.
8.
go back to reference Liu G, Long M, Hu X, et al. Effectiveness and safety of warfarin in dialysis patients with atrial fibrillation: a meta-analysis of observational studies. Medicine (Baltimore). 2015;94(50):e2233.CrossRef Liu G, Long M, Hu X, et al. Effectiveness and safety of warfarin in dialysis patients with atrial fibrillation: a meta-analysis of observational studies. Medicine (Baltimore). 2015;94(50):e2233.CrossRef
9.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed
10.
go back to reference Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2001.CrossRef Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2001.CrossRef
11.
go back to reference Raggi P, Bellasi A, Gamboa C, et al. All-cause mortality in hemodialysis patients with heart valve calcification. Clin J Am SocNephrol. 2011;6:1990e5. Raggi P, Bellasi A, Gamboa C, et al. All-cause mortality in hemodialysis patients with heart valve calcification. Clin J Am SocNephrol. 2011;6:1990e5.
12.
go back to reference Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am SocNephrol. 2003;14(1):159–68. Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am SocNephrol. 2003;14(1):159–68.
13.
go back to reference Varma R, Aronow WS, McClung JA, et al. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol. 2005;95(6):742–3.CrossRefPubMed Varma R, Aronow WS, McClung JA, et al. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol. 2005;95(6):742–3.CrossRefPubMed
14.
go back to reference Mohamed BA, Yang W, Litt H, et al. Valvular calcification, inflammation, and mortality in dialysis patients. J Heart Valve Dis. 2013;22(4):584–90.PubMed Mohamed BA, Yang W, Litt H, et al. Valvular calcification, inflammation, and mortality in dialysis patients. J Heart Valve Dis. 2013;22(4):584–90.PubMed
15.
go back to reference ZL LI, He CS, Yh C, et al. Association of heart valve calcification with cardiovascular outcomes in patients on maintenance hemodialysis. J South Med Univ. 2016;36(7):941–6. ZL LI, He CS, Yh C, et al. Association of heart valve calcification with cardiovascular outcomes in patients on maintenance hemodialysis. J South Med Univ. 2016;36(7):941–6.
16.
go back to reference Zhong B, Na Y. Influence of cardiac valve calcification to all-cause mortality in chronic hemodialysis patients. J Nephrol Dialy Transplant. 2011;20(6):512–6. Zhong B, Na Y. Influence of cardiac valve calcification to all-cause mortality in chronic hemodialysis patients. J Nephrol Dialy Transplant. 2011;20(6):512–6.
17.
go back to reference Wang CY. Risk factor analysis of calcification in aortic and mitral valves and survival in maintenance peritoneal dialysis patients[D].Su Zhou: Su Zhou University. 2014:1-48. Wang CY. Risk factor analysis of calcification in aortic and mitral valves and survival in maintenance peritoneal dialysis patients[D].Su Zhou: Su Zhou University. 2014:1-48.
18.
go back to reference Chen XN, Chen ZJ, Ma XB, et al. Aortic artery and cardiac valve calcification are associated with mortality in Chinese hemodialysis patients: a 3.5 years follow-up. Chin Med J. 2015;128(20):2764–71.CrossRefPubMedPubMedCentral Chen XN, Chen ZJ, Ma XB, et al. Aortic artery and cardiac valve calcification are associated with mortality in Chinese hemodialysis patients: a 3.5 years follow-up. Chin Med J. 2015;128(20):2764–71.CrossRefPubMedPubMedCentral
19.
go back to reference KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Supp. 2009;76(Supp 113s):S1–S130. KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Supp. 2009;76(Supp 113s):S1–S130.
20.
go back to reference Vervloet M, Cozzolino M. Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int. 2017;91(4):808–17.CrossRefPubMed Vervloet M, Cozzolino M. Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int. 2017;91(4):808–17.CrossRefPubMed
21.
go back to reference Choi MJ, Kim JK, Kim SG, et al. Association between cardiac valvular calcification and myocardial ischemia in asymptomatic high-risk patients with end-stage renal disease. Atherosclerosis. 2013;229(2):369–73.CrossRefPubMed Choi MJ, Kim JK, Kim SG, et al. Association between cardiac valvular calcification and myocardial ischemia in asymptomatic high-risk patients with end-stage renal disease. Atherosclerosis. 2013;229(2):369–73.CrossRefPubMed
22.
go back to reference Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998;13:2037e40.CrossRef Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998;13:2037e40.CrossRef
23.
go back to reference Gallieni M, Caputo F, Filippini A, et al. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: a prospective study. Bone. 2012;51(3):332–7.CrossRefPubMed Gallieni M, Caputo F, Filippini A, et al. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: a prospective study. Bone. 2012;51(3):332–7.CrossRefPubMed
24.
go back to reference Sayarlioglu H, Acar G, Sahin M, et al. Prevalence and risk factors of valvular calcification in hemodialysis patients. Iran J Kidney Dis. 2013;7(2):129–34.PubMed Sayarlioglu H, Acar G, Sahin M, et al. Prevalence and risk factors of valvular calcification in hemodialysis patients. Iran J Kidney Dis. 2013;7(2):129–34.PubMed
25.
go back to reference Strózecki P, Odrowaz-Sypniewska G, Manitius J, et al. Cardiac valve calcifications and left entricular hypertrophy in hemodialysis patients. Ren Fail. 2005;27(6):733–8.CrossRefPubMed Strózecki P, Odrowaz-Sypniewska G, Manitius J, et al. Cardiac valve calcifications and left entricular hypertrophy in hemodialysis patients. Ren Fail. 2005;27(6):733–8.CrossRefPubMed
26.
go back to reference Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium- phosphate metabolism. Nephrol Dial Transplant. 1998;13(8):2037–40.CrossRefPubMed Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium- phosphate metabolism. Nephrol Dial Transplant. 1998;13(8):2037–40.CrossRefPubMed
27.
go back to reference Kitamura K, Fujii H, Nakai K, et al. Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation. Heart Vessel. 2017;21 [Epub ahead of print] Kitamura K, Fujii H, Nakai K, et al. Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation. Heart Vessel. 2017;21 [Epub ahead of print]
28.
go back to reference Bellasi A, Ferramosca E, Ratti C, et al. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol. 2012;25:211e8.CrossRef Bellasi A, Ferramosca E, Ratti C, et al. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol. 2012;25:211e8.CrossRef
29.
go back to reference Jamal SA, Vandermeer B, Raggi P, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013;382(9900):1268–77.CrossRefPubMed Jamal SA, Vandermeer B, Raggi P, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013;382(9900):1268–77.CrossRefPubMed
30.
go back to reference Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters. Kidney Int. 2017;92(1):26–36.CrossRefPubMed Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters. Kidney Int. 2017;92(1):26–36.CrossRefPubMed
Metadata
Title
Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis
Authors
Zhe Wang
Aili Jiang
Fang Wei
Haiyan Chen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0747-y

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue